Published in
Elsevier, Antiviral Research, (120), p. 112-121, 2015
DOI: 10.1016/j.antiviral.2015.05.011
Links
Tools
In vitro combinations containing Tegobuvir are highly efficient in curing cells from HCV replicon and in delaying/preventing the development of drug resistance
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 